Loading
BT
Blonder Tongue Laboratories Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Alterio Ronald Vincent, was filed 31 May 2019.
Blonder Tongue Laboratories Inc: what insiders have been doing
Blonder Tongue Laboratories Inc, classified in the Technology sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). Nothing new has been filed by managers of Blonder Tongue Laboratories Inc in twelve months, the latest record being from 3 January 2023.
Our records for Blonder Tongue Laboratories Inc go back to 2006, with 125 purchases and 229 sales on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
823
Thresholds
n/a
Buy Volume
€547,372
125 ops. · all time
Sell Volume
€2M
229 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
RevenueUS$15.6M
Gross profitUS$4.7M30% margin
Net income-US$2.5M-16.1% margin
Last declaration on 3 January 2023
Declarations823 total
5,466 shares@ US$0.191.2% of flowCommon Stock, par value $0.001SEC:0001213900-23-000441:0
2,783 shares@ US$0.191.9% of flowCommon Stock, par value $0.001SEC:0001213900-23-000444:0
2,024 shares@ US$0.191.7% of flowCommon Stock, par value $0.001SEC:0001213900-23-000443:0
2,262 shares@ US$0.171.7% of flowCommon Stock, par value $0.001SEC:0001213900-22-080928:0
3,111 shares@ US$0.171.9% of flowCommon Stock, par value $0.001SEC:0001213900-22-080932:0
6,109 shares@ US$0.171.2% of flowCommon Stock, par value $0.001SEC:0001213900-22-080922:0
4,945 shares@ US$0.211.2% of flowCommon Stock, par value $0.001SEC:0001213900-22-077629:0
2,518 shares@ US$0.211.9% of flowCommon Stock, par value $0.001SEC:0001213900-22-077628:0
1,832 shares@ US$0.211.7% of flowCommon Stock, par value $0.001SEC:0001213900-22-077630:0
45,653 shares@ US$0.202.2% of flowCommon Stock, par value $0.001SEC:0001213900-22-074232:1
5,192 shares@ US$0.201.3% of flowCommon Stock, par value $0.001SEC:0001213900-22-074232:0
2,644 shares@ US$0.201.9% of flowCommon Stock, par value $0.001SEC:0001213900-22-074233:0
1,923 shares@ US$0.201.7% of flowCommon Stock, par value $0.001SEC:0001213900-22-074234:0
50,725 shares@ US$0.182.3% of flowCommon Stock, par value $0.001SEC:0001213900-22-069754:1
5,769 shares@ US$0.181.3% of flowCommon Stock, par value $0.001SEC:0001213900-22-069754:0
2,137 shares@ US$0.181.8% of flowCommon Stock, par value $0.001SEC:0001213900-22-069756:0
2,938 shares@ US$0.182.1% of flowCommon Stock, par value $0.001SEC:0001213900-22-069755:0
60,870 shares@ US$0.152.3% of flowCommon Stock, par value $0.001SEC:0001213900-22-065835:1
2,564 shares@ US$0.151.8% of flowCommon Stock, par value $0.001SEC:0001213900-22-065834:0
3,526 shares@ US$0.152.1% of flowCommon Stock, par value $0.001SEC:0001213900-22-065833:0
6,923 shares@ US$0.151.3% of flowCommon Stock, par value $0.001SEC:0001213900-22-065835:0
6,109 shares@ US$0.171.3% of flowCommon Stock, par value $0.001SEC:0001213900-22-063008:0
3,111 shares@ US$0.172.0% of flowCommon Stock, par value $0.001SEC:0001213900-22-063012:0
53,709 shares@ US$0.1711.8% of flowCommon Stock, par value $0.001SEC:0001213900-22-063008:1
2,262 shares@ US$0.171.8% of flowCommon Stock, par value $0.001SEC:0001213900-22-063010:0
25 of 823 declarations
About Blonder Tongue Laboratories Inc
Blonder Tongue Laboratories, Inc. is a U.S.-based technology and manufacturing company whose common stock is associated with ticker BDR and has historically traded on NYSE American within the NYSE/NASDAQ ecosystem, in the United States. The company traces its roots back to 1950, when Ben H. Tongue and Isaac S. Blonder founded the original Blonder-Tongue Laboratories in New Jersey to design and supply electronic systems for the private cable industry. The modern company was later formed through the acquisition of that business and remains focused on communications infrastructure. ([blondertongue.com](https://www.blondertongue.com/wp-content/uploads/Blonder-Tongue-2024-Annual-Report-Final.pdf))
Today, Blonder Tongue operates as a niche developer and manufacturer of television signal encoding, transcoding, digital transport, broadband, and video distribution solutions. Its portfolio spans encoder/transcoder platforms, digital transport equipment, EdgeQAM products, analog modulation, coaxial distribution, DOCSIS-related products, and other video/network hardware used by telecom operators, cable operators, fiber and broadband service providers, system integrators, and enterprise/institutional customers. The company’s end markets include lodging and hospitality, MDU/apartment complexes, campuses, hospitals, schools, prisons, government facilities, airports, sports venues, casinos, retail, and small to mid-sized businesses. ([blondertongue.com](https://www.blondertongue.com/wp-content/uploads/Blonder-Tongue-2024-Annual-Report-Final.pdf))
Read moreShow less
From a competitive standpoint, Blonder Tongue is best viewed as a specialized small-cap supplier rather than a broad-line communications equipment vendor. Its strategy emphasizes engineering know-how, product customization, and cost-effective deployment for customers that need private video and data networks. Manufacturing is centered primarily at its Old Bridge, New Jersey facility, while selected high-volume or labor-intensive products are also manufactured through contract partners in China, South Korea, and Taiwan. This mixed model is designed to balance cost control with time-to-market and operational flexibility. ([blondertongue.com](https://www.blondertongue.com/wp-content/uploads/Blonder-Tongue-2024-Annual-Report-Final.pdf))
Recent operating trends are important for investors. In its 2024 annual report, the company said net sales fell to $11.165 million from $13.213 million in 2023, mainly due to lower encoder/transcoder and analog modulation sales, partly offset by higher coax distribution sales. In the first quarter of 2025, however, sales rose to $2.919 million from $2.643 million a year earlier, led by NXG products and DOCSIS products, with management citing stronger purchases from its largest NXG customer and a recovery in hospitality demand. ([blondertongue.com](https://www.blondertongue.com/wp-content/uploads/Blonder-Tongue-2024-Annual-Report-Final.pdf))
The investment case remains balanced by meaningful financial risk. The company has disclosed liquidity constraints, customer and vendor concentration, and in its 2024 report continued to highlight substantial doubt about its ability to continue as a going concern. The first-quarter 2025 report again noted that existing liquidity and operating cash flow may not be sufficient without materially improving revenue and lowering operating expenses. For French-, Belgian- and Swiss-based investors, Blonder Tongue is therefore a high-risk turnaround-style micro/small cap with exposure to legacy cable infrastructure, hospitality networks, and the ongoing migration toward fiber and Ethernet-based distribution. ([blondertongue.com](https://www.blondertongue.com/wp-content/uploads/Blonder-Tongue-2024-Annual-Report-Final.pdf))
